Study: NCT01500382

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo (vibegron)
Description: Inactive agent in tablet form, oral administration, once daily, up to 5 weeks, based on treatment assignment in each treatment period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo (vibegron)
Description: Inactive agent in tablet form, oral administration, once daily, up to 5 weeks, based on treatment assignment in each treatment period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo (vibegron)
Description: Inactive agent in tablet form, oral administration, once daily, up to 5 weeks, based on treatment assignment in each treatment period.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (tolterodine ER)
Description: Inactive agent in capsule form, oral administration, once daily, up to 5 weeks, based on treatment assignment in each treatment period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo (tolterodine ER)
Description: Inactive agent in capsule form, oral administration, once daily, up to 5 weeks, based on treatment assignment in each treatment period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo (tolterodine ER)
Description: Inactive agent in capsule form, oral administration, once daily, up to 5 weeks, based on treatment assignment in each treatment period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo (tolterodine ER)
Description: Inactive agent in capsule form, oral administration, once daily, up to 5 weeks, based on treatment assignment in each treatment period.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prophylactic Antibiotic
Description: A pre-procedural prophylactic antibiotic (ie, levofloxacin 250 mg, cephalexin) administered orally, 30 minutes prior to each scheduled urodynamic study intervention. It is up to the discretion of the Investigator, based on study protocol recommendations, as to which type of antibiotic may be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylactic Antibiotic
Description: A pre-procedural prophylactic antibiotic (ie, levofloxacin 250 mg, cephalexin) administered orally, 30 minutes prior to each scheduled urodynamic study intervention. It is up to the discretion of the Investigator, based on study protocol recommendations, as to which type of antibiotic may be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylactic Antibiotic
Description: A pre-procedural prophylactic antibiotic (ie, levofloxacin 250 mg, cephalexin) administered orally, 30 minutes prior to each scheduled urodynamic study intervention. It is up to the discretion of the Investigator, based on study protocol recommendations, as to which type of antibiotic may be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylactic Antibiotic
Description: A pre-procedural prophylactic antibiotic (ie, levofloxacin 250 mg, cephalexin) administered orally, 30 minutes prior to each scheduled urodynamic study intervention. It is up to the discretion of the Investigator, based on study protocol recommendations, as to which type of antibiotic may be administered.